Source: Journal of clinical pathology. Unidade: FM
Subjects: PROGNÓSTICO, TERAPIA COMBINADA, NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA
ABNT
CUNHA, Juliana Pierobon Gomes da et al. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy. Journal of clinical pathology. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/53967. Acesso em: 23 ago. 2024. , 2023APA
Cunha, J. P. G. da, Goncalves, R., Silva, F., Aguiar, F. N., Mota, B. S., Chequin, B. B., et al. (2023). Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy. Journal of clinical pathology. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1136/jclinpath-2021-207771NLM
Cunha JPG da, Goncalves R, Silva F, Aguiar FN, Mota BS, Chequin BB, Soares Junior JM, Baracat EC, Filassi JR. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy [Internet]. Journal of clinical pathology. 2023 ; 76( 4): 239-243.[citado 2024 ago. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53967Vancouver
Cunha JPG da, Goncalves R, Silva F, Aguiar FN, Mota BS, Chequin BB, Soares Junior JM, Baracat EC, Filassi JR. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy [Internet]. Journal of clinical pathology. 2023 ; 76( 4): 239-243.[citado 2024 ago. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53967